Xenobiotic polymers as vaccine vehicles.
Payne
L G
LG
Virus Research Institute, Inc., Cambridge, MA, USA.
Jenkins
S A
SA
Andrianov
A
A
Langer
R
R
Roberts
B E
BE
D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D001673:Biodegradation, Environmental; D002214:Capsules; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D006801:Humans; D018928:Immunity, Mucosal; D009943:Organophosphorus Compounds / Q000008:administration & dosage; D010581:Peyer's Patches / Q000276:immunology; D014677:Pharmaceutical Vehicles; D011107:Polylysine / Q000008:administration & dosage; D011108:Polymers / Q000008:administration & dosage*; D014612:Vaccines / Q000008:administration & dosage*; D015262:Xenobiotics / Q000008:administration & dosage*
D000941:Antigens; D002214:Capsules; D003692:Delayed-Action Preparations; D009943:Organophosphorus Compounds; D014677:Pharmaceutical Vehicles; D011108:Polymers; D014612:Vaccines; D015262:Xenobiotics; D011107:Polylysine